Charlotte Coe, a State Department IT specialist, spent eight years on hormone therapy and six years undergoing surgeries — including a vaginoplasty that left wounds that kept reopening and a urethral lesion. The follow-up procedure, a colovaginoplasty, cost $100,000. Coe now describes daily life as feeling like "a constant papercut" that "makes sexual activity of any kind painful and dangerous."
This wasn't some back-alley operation. This was federally insured care, encouraged by the government's own health plans.
Coe is one of three pseudonymous class representatives — alongside Vanessa Voe, a War Department researcher, and a plaintiff identified as Christine F. — suing after the Trump administration moved to eliminate federal insurance coverage for so-called "gender affirming care" starting in 2027. The lawsuit, filed in federal court in Washington, D.C. and tracked as case DCD 295146, argues that cutting off coverage now amounts to abandoning employees mid-treatment. The complaint compares it to "denying continuing insulin treatment for someone with diabetes."
That framing tells you everything about where the plaintiffs' attorneys think the leverage is. They're not arguing the procedures worked. They're arguing the employees are now dependent on continued treatment because the procedures didn't.
Voe, the War Department researcher, states in the complaint that without ongoing hormone replacement therapy, "my body suffers irreversible harm." Think about that sentence. The treatment marketed as life-saving has created a permanent dependency — and the harm Voe describes isn't from stopping some external illness. It's from what the treatment itself did to a healthy endocrine system.
The medical establishment sold these procedures under the banner of the World Professional Association for Transgender Health, known as WPATH — the same organization whose own leaked files revealed internal doubts about the evidence base for the interventions they were recommending. The Society for Evidence-Based Gender Medicine has been raising alarms for years. A jury in a separate malpractice case already awarded detransitioner Fox Varian $2 million. Maddie Durbin, another detransitioner, has become one of the most visible voices documenting the physical toll.
The lawsuit invokes Bostock v. Clayton County, the Supreme Court ruling that extended Title VII protections to gender identity in employment. The plaintiffs argue that stripping their insurance coverage constitutes workplace discrimination. The 10th U.S. Circuit Court of Appeals issued a ruling in February 2025 that touched on similar questions in a case involving Darlene Griffith and Colorado prison policies in El Paso County. The legal terrain is active and unsettled.
But here's what the complaint doesn't grapple with: the federal government covering these procedures in the first place is what created the plaintiffs. These employees didn't walk into a clinic on their own and negotiate a price. They used a benefit their employer provided, underwent procedures their employer's insurance approved, and are now dealing with consequences their employer's medical gatekeepers never adequately warned them about. The system told them yes at every step. Now they need the system to keep saying yes because the first yes broke something.
The Equal Employment Opportunity Commission under the previous administration pushed agencies to treat these procedures as routine medical care. The FTC went after anyone who questioned the safety claims too loudly. States like Tennessee and West Virginia passed bans on these procedures for minors, and the federal apparatus fought those bans in court. The entire institutional weight of the government said this was safe, necessary, and settled science.
The employees believed it. Charlotte Coe believed it through eight years of hormones and six years of surgeries and a $100,000 follow-up procedure that still left daily pain. Vanessa Voe believed it until the dependency became permanent.
They're not suing because a right-wing administration is being cruel. They're suing because the care itself was the damage, and now they need more of it to manage what the first round did.
The government's own workforce is now Exhibit A. The plaintiffs aren't critics. They're customers.
